BNET Industries

Techne Corp.

(TECH) is in the Pharma Industry

Market Cap:$2.5B
Last Fiscal Year Sales:$257.4M
  • Public
  • US
Dow Jones Description

TECHNE Corporation (NASDAQ: TECH), incorporated in Minnesota in 1981, is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (RDSE) located in Abingdon, England. R&D Systems is a specialty manufacturer of biological products. It has two operating divisions: Hematology and Biotechnology. The Hematology Division develops and manufactures hematology controls, which are used in hospitals and clinical laboratories to check the accuracy of blood analysis instruments. The Biotechnology Division develops and manufactures biotechnology products including purified proteins (cytokines) and antibodies that are sold primarily to the research market, and assay kits which are sold to the research and clinical diagnostic markets. Over 95% of TECHNE?s revenues are derived from products manufactured by R&D Systems. R&D Systems has two subsidiaries: R&D Systems China Co. Ltd. and BiosPacific, Inc. RDSE sells and distributes R&D Systems' biotechnology products in Europe. RDSE has a German sales subsidiary, R&D Systems GmbH.

Chairman, President & CEO
Thomas E. Oland
Number of Employees 666
Contact Information

614 McKinley Place N.E.

Minneapolis, Minnesota 55413-2610

www.techne-corp...

(612) 379-8854

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Techne Corp reports dividend of USD0.26 per share

    10/30/09 - Stock Split / Dividend - View Story

  • Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010

    10/28/09 - Financial Announcement - View Story

  • Techne Corp. TECH Declares Dividend

    8/04/09 - Stock Split / Dividend - View Story

News & Analysis

techne corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Gregory J. Melsen CFO & Vice President, Finance
Richard Krzyzek Chief Scientific Officer
James Weatherbee Vice President
Marcel Veronneau Vice President, Hematology Operations
Monica Tsang Vice President, Res
Timothy M. Heaney General Counsel, Vice President & Secretary
Jennifer Harrington Director, Marketing
Kathy Backes Controller

Board of Directors

Name (plus bio) Position
Thomas E. Oland Chairman, President & CEO
Charles A. Dinarello Board of Directors
G. Arthur Herbert Board of Directors
Howard V. O'Connell Board of Directors
John L. Higgins Board of Directors
Robert V. Baumgartner Board of Directors

Organization Position Status
TECHNE CORPORATION Chairman, President & CEO Current
R&D Systems Inc. President Current

Organization Position Status
TECHNE CORPORATION CFO & Vice President, Finance Current
TECHNE CORPORATION Board of Directors Current

Organization Position Status
TECHNE CORPORATION Chief Scientific Officer Current

Organization Position Status
TECHNE CORPORATION Vice President Current

Organization Position Status
TECHNE CORPORATION Vice President, Hematology Operations Current

Organization Position Status
TECHNE CORPORATION Vice President, Res Current
TECHNE CORPORATION Board of Directors Current

Organization Position Status
TECHNE CORPORATION General Counsel, Vice President & Secretary Current

Organization Position Status
TECHNE CORPORATION Director, Marketing Current
TECHNE CORPORATION Director, Marketing Former

Organization Position Status
R&D Systems Inc. Chief Accounting Officer & Controller Current
TECHNE CORPORATION Controller Current
R&D Systems Inc. Controller Former

Organization Position Status
University of Colorado School of Medicine Professor of Medicine Current
Iap-Cme Current
Point Therapeutics Current
Inhibitex, Inc. Current
Genexion Sa. Current
TECHNE CORPORATION Board of Directors Current
Orthologic Corporation Board of Directors Current
National Academy of Sciences Board of Directors Current
Keel Pharmaceuticals, Inc. Board of Directors Current
Senesco Technologies Inc. Board of Directors Current
Sciences, Inc Board of Directors Current
Sciences, Inc Member Current
National Academy of Sciences Member Current
Tufts University School of Medicine Professor of Medicine Former
National Institutes of Health Senior Investigator Former
Massachusetts General Hospital Former
TECHNE CORPORATION Director Former
GlobeImmune Inc. Board of Directors Former
Weizmann Institute of Science Degree Former
Yale University Degree Former

Mr. Herbert has served as the Principal of CEO Advisors, a management and financial consulting firm, since 1989. From 1969 to 1988 he was the President and Vice President - Manager of Electro-Science Management Corporation, a manager of three venture capital partnerships. Mr. Herbert serves on the board of publicly held Techne Corporation and several privately held businesses. He received his Masters in Business Administration from Harvard University and Bachelor of Science in Engineering from the United States Naval Academy.

Organization Position Status
The Blue Orb CEO Current
The Blue Orb Director Current
TECHNE CORPORATION Board of Directors Current
The Blue Orb Principal Former
Harvard University Masters In Business Administration Former

Organization Position Status
TECHNE CORPORATION Board of Directors Current

John L. Higgins is President, Chief Executive Officer and a member of the Board of Directors of Ligand Pharmaceuticals Inc. Prior to joining Ligand, Mr. Higgins served as Chief Financial Officer and Executive Vice President, Finance and Administration and Corporate Development, of Connetics Corporation, a specialty pharmaceutical company acquired by Stiefel Laboratories in December 2006. Before joining Connetics, he was a member of the executive management team at BioCryst Pharmaceuticals. Currently, he is a Director on the Boards of Techne Corporation, CoMentis and BioCryst and serves as Chairperson on the BioCryst Audit Committee. Prior to BioCryst, Mr. Higgins was a member of the healthcare banking team of Dillon, Read & Co. Inc., an investment banking firm. Mr. Higgins serves as a director of numerous public and private companies. He graduated Magna Cum Laude from Colgate University with an AB in economics.

Organization Position Status
Ligand Pharmaceuticals Incorporated President & CEO Current
TECHNE CORPORATION Board of Directors Current
Ligand Pharmaceuticals Incorporated Board of Directors Current

Organization Position Status
TECHNE CORPORATION Board of Directors Current

Executive News

  • Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix

    Pharma Live - 6/28/09 - View Story

  • Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix

    RBC Dain Raushcer - 6/25/09 - View Story

  • Dr. Eli Lewis Joins the Omni Bio Pharmaceutical Scientific

    Market Wire via MSN Money - 6/24/09 - View Story

  • Dr. Eli Lewis Joins the Omni Bio Pharmaceutical Scientific Advisory Board

    Market Wire - 6/24/09 - View Story

  • Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors

    PR Newswire - 5/19/09 - View Story

  • Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board

    PR Newswire via Yahoo! - 5/19/09 - View Story

  • Techne announces board changes

    The Minneapolis/St. Paul Business Journal - 5/19/09 - View Story

advertisement
     TECH $67.51 -0.02 (-0.03% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 124,188
Shares Outstanding 37.25M
Market Cap 2.5B
Year High 68.23
Year Low 45.38
Earnings Per Share 2.76
P/E Ratio 24.46
Dividend 1.04
Yield 1.54
IndustryTop Rated
advertisement
Click Here